News
11-06-2008, 05:32 AM
Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. A new study appearing in Clinical and Translational Science shows the mechanisms governing stem cell expansion in breast cancer (called Notch activity), and finds that therapy targeting a protein called cyclin D1 may block the expansion of cancerous stem cells. The study, conducted by Dr.
More... (http://www.medicalnewstoday.com/articles/128357.php)
More... (http://www.medicalnewstoday.com/articles/128357.php)